Tasker’s technology gets approval for use in food processing
Tasker’s proprietary technology is highly effective in inhibiting pathogenic bacteria.
11/11/05 Tasker Capital Corp., a distributor and marketer of a proprietary technology that is highly effective in inhibiting pathogenic bacteria, has announced that it has received approval from the New Zealand Food Safety Authority ("FSA") for the use of its technology in aqueous solutions as an antibacterial processing aid in the production of meat, poultry and seafood in New Zealand and Australia. The FSA's notification made reference to the fact that the United States Food and Drug Administration ("FDA") has confirmed that the ingredients may be used as processing aids. New Zealand's FSA stated that, in their view, the (pHarlo) solutions are made of ingredients permitted as processing aids under the Australia New Zealand Food Standards Code (FSC Std) 1.3.3 at levels according to Good Manufacturing Practice.
Livestock, poultry and seafood are big business in New Zealand and Australia. Recent data indicates that New Zealand and Australia, combined, have about 37 million cattle, and 200 million sheep. They process approximately 9.9 million beef cattle, 37.4 million sheep, and approximately 845 million pounds of poultry, and produce 249 million eggs, annually. In addition, Australia processes 16.9 million lamb and 7.5 million pigs, annually. Processing sanitation is closely monitored by both governments.
Tasker Products is a manufacturer, distributor and marketer of products using a unique, licensed patented process that utilizes a highly charged, acidified, yet stable and safe solution that enables copper sulfate, widely known for its bacteriostatic properties to remain active throughout a wide range of pH values. The company is continuing its clinical research and development of future products in the oral care, food processing, skin care and pet products industries. Tasker Capital Corp. is headquartered in Danbury, Connecticut.
